We are live on ! Find out more
GCIA

Gabelli & Co Investment Advisers Portfolio holdings

AUM $674M
1-Year Est. Return 64.46%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+64.46%
3 Year Est. Return
+233.2%
5 Year Est. Return
+564.06%
10 Year Est. Return
+5,311.56%
AUM
$651M
AUM Growth
-$10.4M
Cap. Flow
-$40.4M
Cap. Flow %
-6.21%
Top 10 Hldgs %
33.34%
Holding
313
New
62
Increased
51
Reduced
31
Closed
48

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$19M
2
SKX
Skechers
SKX
+$16.5M
3
SWTX
SpringWorks Therapeutics
SWTX
+$12.6M
4
WBA
Walgreens Boots Alliance
WBA
+$9.26M
5
DNB
Dun & Bradstreet
DNB
+$7.98M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$26.7M
2
FNA
Paragon 28, Inc.
FNA
+$18.3M
3
BECN
Beacon Roofing Supply, Inc.
BECN
+$18M
4
DFS
Discover Financial Services
DFS
+$16.7M
5
DESP
Despegar.com
DESP
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.22%
2 Communication Services 15.3%
3 Technology 11.49%
4 Industrials 8.49%
5 Consumer Discretionary 8.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LCCCU
101
Lakeshore Acquisition III Corp Unit
LCCCU
$1.16M 0.18%
+113,900
New +$1.15M
TXN icon
102
Texas Instruments
TXN
$256B
$1.15M 0.18%
5,550
+2,000
+56% +$355K
CSCO icon
103
Cisco
CSCO
$477B
$1.14M 0.18%
16,500
– –
NXPI icon
104
NXP Semiconductors
NXPI
$59.4B
$1.14M 0.17%
5,200
+200
+4% +$39.1K
SONY icon
105
Sony
SONY
$138B
$1.12M 0.17%
42,925
-2,575
-6% -$64.4K
CNNE icon
106
Cannae Holdings
CNNE
$645M
$1.12M 0.17%
+53,500
New +$988K
GGZ
107
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$127M
$1.1M 0.17%
82,711
– –
ASPC
108
A SPAC III Acquisition Corp
ASPC
$24.7M
$1.06M 0.16%
103,200
– –
HGTY icon
109
Hagerty
HGTY
$1.3B
$1.04M 0.16%
103,300
– –
CTLP
110
DELISTED
Cantaloupe
CTLP
$1.01M 0.16%
+92,100
New +$797K
ALIT icon
111
Alight
ALIT
$369M
$1.01M 0.16%
8,918
-310
-3% -$33.2K
BOOM icon
112
DMC Global
BOOM
$158M
$989K 0.15%
122,700
+7,050
+6% +$49.8K
CNH
113
CNH Industrial
CNH
$17.1B
$972K 0.15%
75,000
-4,000
-5% -$49.4K
EURK
114
Eureka Acquisition Corp
EURK
$930K 0.14%
89,200
– –
TV icon
115
Televisa
TV
$1.48B
$889K 0.14%
405,950
+10,000
+3% +$19.6K
GLW icon
116
Corning
GLW
$137B
$799K 0.12%
15,200
-500
-3% -$23.4K
BA icon
117
Boeing
BA
$184B
$796K 0.12%
3,800
– –
WBD icon
118
Warner Bros
WBD
$68B
$773K 0.12%
67,450
+10,248
+18% +$95.6K
MANU icon
119
Manchester United
MANU
$3.83B
$736K 0.11%
41,345
-21,850
-35% -$324K
GM icon
120
General Motors
GM
$78.2B
$723K 0.11%
14,700
– –
HRI icon
121
Herc Holdings
HRI
$5.73B
$705K 0.11%
+5,350
New +$649K
GRFS
122
Grifois
GRFS
$5.44B
$703K 0.11%
77,728
– –
OBAWU
123
Oxley Bridge Acquisition Ltd Unit
OBAWU
$699K 0.11%
+69,800
New +$699K
MTAL
124
DELISTED
Metals Acquisition
MTAL
$698K 0.11%
+57,750
New +$597K
CPRT icon
125
Copart
CPRT
$27.3B
$687K 0.11%
14,000
– –
3 4
5
6 7

Similar funds

RCM
Redwood Capital Management New York $674M AUM 99.78% 1-Year Est. Return
DPC
Dream Peak Capital Hong Kong $675M AUM
BFA
Blueprint Financial Advisors Greensboto, North Carolina $675M AUM 24.91% 1-Year Est. Return
CCM
Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return
CHCM
Columbus Hill Capital Management Short Hills, New Jersey $673M AUM 24.63% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
NI
Noked Israel Ramat Hasharon, Israel $677M AUM 69.37% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Gabelli & Co Investment Advisers's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli & Co Investment Advisers held 313 positions worth $651M, down 1.6% from $662M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Gabelli & Co Investment Advisers withdrew a net $40.4M in Q2 2025, closing 48 positions and reducing 31 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $26.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Gabelli & Co Investment Advisers opened a new position in Blueprint Medicines worth $23.5M.

  • Gabelli & Co Investment Advisers's largest Q2 2025 buy was Blueprint Medicines: 183,374 shares worth $23.5M.
  • Gabelli & Co Investment Advisers added most to SpringWorks Therapeutics in Q2 2025, an estimated $12.6M increase.
  • Gabelli & Co Investment Advisers's biggest Q2 2025 reduction was Albertsons Companies, cutting an estimated $4.03M.
  • Gabelli & Co Investment Advisers fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $26.7M.
  • Gabelli & Co Investment Advisers's ten largest holdings make up 33% of its $651M portfolio in Q2 2025.
  • Gabelli & Co Investment Advisers opened 62 new positions and closed 48 in Q2 2025.
  • Gabelli & Co Investment Advisers's portfolio value fell 1.6% quarter-over-quarter to $651M.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.